Article
Genomic Signatures and Functional Pathways Underlying 5-Fluorouracil Resistance in Head and Neck Cancer associated Streptococci
2026-02-25
Abstract excerpt
<title>Abstract</title> <p> The chemotherapeutic agent 5-fluorouracil (5-FU), widely used in the treatment of head and neck cancer (HNC), also exhibits broad antimicrobial activity, yet fluoropyrimidine resistance within HNC-associated microbiota remains poorly characterised. We assessed 5-FU susceptibility and resistance-associated genomic features in 101 <italic>Streptococcus</italic> isolates obtained from...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 2eb464c5-b7f3-5202-990d-0fb03c84af1c
- DOI
- 10.21203/rs.3.rs-8825984/v1
